Avid Bioservices Inc (CDMO)

[stockaxe]

Three more reports this year, including late June when they will give annual guidance. I think backlog could be lumpy, but assuming the trajectory overall continues to be positive with backlog and margins, you should see the stock continue to perform well in my opinion.